Provided By PR Newswire
Last update: Feb 11, 2025
The ex-vivo testing demonstrated significant bacterial reduction for the innovative IV dressing technology aimed at preventing bloodstream infections in critical patients
Read more at prnewswire.comNASDAQ:IINN (10/31/2025, 4:30:02 PM)
0.93
0 (0%)
Find more stocks in the Stock Screener



